The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Chemoradiotherapy (CRT) for locally-advanced (LA) lung cancer patients with interstitial lung abnormalities (ILA).
 
Toshio Kubo
No Relationships to Disclose
 
Hisao Higo
No Relationships to Disclose
 
Takashi Ninomiya
Honoraria - Chugai Pharma; Merck Serono; Nippon Boehringer Ingelheim
Research Funding - AstraZeneca Japan (Inst); Daiichi Sankyo (Inst); Nippon Boehringer Ingelheim (Inst); Nippon Kayaku (Inst); Shionogi (Inst)
 
Eiki Ichihara
No Relationships to Disclose
 
Kadoaki Ohashi
Honoraria - AstraZeneca Japan; Chugai Pharma
Research Funding - Nippon Boehringer Ingelheim; Novartis
 
Akiko Sato
No Relationships to Disclose
 
Katsuyuki Hotta
Honoraria - AstraZeneca Japan; Bristol-Myers Squibb; Chugai Pharma; Daiichi Sankyo; Kyowa Hakko Kirin; Lilly Japan; Nippon Boehringer Ingelheim; Nippon Kayaku; Ono Pharmaceutical; Pfizer; Taiho Pharmaceutical
Research Funding - Bristol-Myers Squibb; Chugai Pharma; Kyowa Hakko Kirin; Lilly Japan; MSD; Novartis; Ono Pharmaceutical
 
Masahiro Tabata
No Relationships to Disclose
 
Satoko Makimoto
No Relationships to Disclose
 
Hiroki Ihara
No Relationships to Disclose
 
Yoshihisa Masaoka
No Relationships to Disclose
 
Kuniaki Katsui
No Relationships to Disclose
 
Katsuyuki Kiura
Honoraria - Chugai Pharma; Lilly Japan; Novartis; Pfizer; Taiho Pharmaceutical
Research Funding - AstraZeneca Japan; Daiichi Sankyo; Nippon Boehringer Ingelheim; Nippon Kayaku; Shionogi